Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Tight liquidity NBB
Cash and receivables cover 3 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
Farma&Cie from Edegem, company number BE0668680188, closed financial year 2025 with a result of € 140,442 after tax. For that financial year Farma&Cie recorded a gross margin of € 203,669 and equity of € 899,986. Compared with financial year 2024, the result moved from € 187,969 to € 140,442. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 17, 2026.
€ 899,986
▲ 18% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 140,442
▼ 25% vs 2024
Profit after tax over the fiscal year.
€ 19,760
▼ 76% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 881,386.
Debts at end 2025
€ 1 million
▼ 20% vs 2024
€ 148,308 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.
€ 579
▼ 18% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 45,338
▼ 50% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 194,111 | € 253,127 | € 220,358 | € 203,669 | ▼ 8% |
| Profit after taxes | € 118,076 | € 212,493 | € 187,969 | € 140,442 | ▼ 25% |
| Equity | € 359,082 | € 571,575 | € 759,544 | € 899,986 | ▲ 18% |
| Total debts | € 2,316,441 | € 2,194,518 | € 2,070,577 | € 1,792,934 | ▼ 13% |
| Cash | € 12,132 | € 89,931 | € 82,805 | € 19,760 | ▼ 76% |
| Retained profit | € 340,482 | € 552,975 | € 740,944 | € 881,386 | ▲ 19% |
| Bank debt | € 1,548,827 | € 1,406,173 | € 1,261,658 | € 1,015,260 | ▼ 20% |
| Balance sheet total | € 2,675,523 | € 2,766,093 | € 2,830,121 | € 2,692,921 | ▼ 5% |
Key figures of Farma&Cie, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Farma&Cie?
What happened at Farma&Cie in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 140,442 (▼ 25% vs 2024). filed late Source: NBB ↗
- New establishment in Edegem. KBO
- Carolien Van Assche became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 118,076 profit in 2022 to € 140,442 profit in 2025.
Paid € 256,481 in corporate taxes since 2022.
Best year ever: 2023, with € 212,493 profit.
Management
Behind Farma&Cie is Carolien Van Assche. It owns 100% of Apotheek Van Assche and 49.1% of Apotheek Smet & Van Assche itself.
Directors
According to the 2025 annual accounts
since 2017
Establishments
Establishment units
Physical locations of this company
Ferdinand Verbiestlaan 41
2650 Edegem
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0668.680.188
- VAT number
- BE 0668.680.188
- Registered office
- Ferdinand Verbiestlaan 41, 2650 Edegem
- Names & denominations
- Farma&Cie
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 3 January 2017
- Peppol
- Active · Active since 26 Nov 2025
- Activities · NACE
Activiteiten van holdings
Holdings